Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211353 · ClinicalTrials.gov registry record · NA
Personalized Drinking Feedback Interventions
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT01211353: Completed NA study, sponsored by University of Missouri-Columbia.
NCT01211353 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 325 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01211353, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
The objective of this research is to better understand how to reduce hazardous drinking among OEF/OIF veterans by assessing the effectiveness of a low-cost, computer-delivered preventative program.
Primary Outcome
Several quantity/frequency measures of alcohol use
Interventions
- BEHAVIORAL Personalized Drinking Feedback
- BEHAVIORAL Education-Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01211353 record still lists
NCT01211353 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Personalized Drinking Feedback is the first listed.
NCT01211353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01211353 about?
NCT01211353 is a clinical study titled "Personalized Drinking Feedback Interventions". The objective of this research is to better understand how to reduce hazardous drinking among OEF/OIF veterans by assessing the effectiveness of a low-cost, computer-delivered preventative program.
What is the current status of trial NCT01211353?
This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2011-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01211353?
The interventions under investigation include: Personalized Drinking Feedback (BEHAVIORAL), Education-Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT01211353?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01211353's enrollment target sits among peer trials
325 311th of 2000 higher than 1,689 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02543983 · 325 participants · Phase 2
Neurobiology of Suicide
- NCT03016819 · 325 participants · Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- NCT03288207 · 325 participants · NA
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- NCT04986657 · 325 participants · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia